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Abstract
Streptococcus iniae infections are becoming an increasing problem in aquaculture and have been reported worldwide
in a variety of fish species. Our previous study showed that S. iniae infection in tilapia Oreochromis sp. and Asian sea bass
Lates calcarifer cause serious damage in fish farm in Thailand. To prevent streptococcosis caused by S. iniae, a formalin-
killed vaccine was applied in red tilapia Oreochromis niloticus x O. mossambicus by injection, immersion and oral vaccina-
tion. At 1 week post vaccination, levels of antibody titer and some blood parameters response to different routes of adminis-
tration were significantly different. The best disease resistance was found in the group injected with vaccine plus -(1,3/1,6)–
glucan with the relative percent survival (RPS) of 95.12% followed by pure vaccine injection (RPS = 80.49%), immersion
(RPS = 41.46%) and oral vaccination (RPS = 9.75%).
No difference in blood parameters of tilapia after vaccination for 4 weeks was observed. However, antibody titer of
the group received vaccine plus -(1,3/1,6)–glucan and vaccine alone were significantly higher than the other groups. RPS of
fish at week 4 post vaccination showed the same trend as the highest disease resistance recorded in the group injected with
vaccine plus -(1,3/1,6)–glucan (RPS=76.00%) which significantly differ from vaccine alone (RPS=54.00%). Immersion and
oral vaccination showed less effect on disease protection at week 4 post vaccination. The result from the present study
indicated that formalin-killed S. iniae vaccine provided excellent efficacy against S. iniae infection in tilapia by intraperto-
neal injection and -(1,3/1,6)–glucan increased the effectiveness of vaccine produced from S. iniae.
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1. Introduction
Streptococcal  infections  in  fish  were  first  detected
among cultured rainbow trout Oncorhynchus mykiss in 1957
in the Shizuoka Prefecture in Japan (Hoshina et al., 1958).
Since then, the disease has increased with outbreaks occur-
ring in yellowtails Seriola quinqueradiata cultured in Japan
resulting in a loss of over 10,000 ton in 1984 (Matsuyama et
al., 1992). Streptococcus iniae, one of the most important
streptococcal  species,  was  first  described  from  captive
Amazon  freshwater  dolphins  Inia  geoffrensis  (Pier  and
Madin, 1976). Subsequently, the bacterium was found to have
spread  to  various  cultured  fish  stocks,  especially  tilapia
Oreochromis  niloticus  and  the  hybrid  O.  niloticus  x  O.
aureus (Al-Harbi, 1994; Perera et al., 1994; Shoemaker et al.,
2000), barramundi Lates calcarifer (Bromage et al., 1999)
and  red  drum  Sciaenops  ocellatus  (Eldar  et  al.,  1999).  In
Thailand, streptococcosis caused by S. agalactiae and S.
iniae  in  tilapia  Oreochromis  sp.  and  Asian  sea  bass  L.
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calcarifer have been reported by our group (Suanyuk et al.,
2005; 2008; 2010). Clinical signs of S. iniae infection in fish
vary  between  species.  However,  the  most  common  signs
include loss of equilibrium, unilateral or bilateral exophthal-
mia,  eye  opacity,  haemorrhages  on  bases  of  the  fins,  and
darkening of skin, (Perera et al., 1994; Bromage et al., 1999;
Eldar et al., 1999; Colorni et al., 2002; Suanyuk et al., 2010).
To prevent and cure bacterial diseases, farmers usu-
ally apply antibiotics and relevant chemicals. Consequences
of this practice are however detrimental and well documented.
For example, residues of antibiotics have been detected both
in cultured organisms and local environments, which can
cause resistance to antibiotics. Vaccination is one tool which
the fish farmers may use to combat disease problems. Vacci-
nation of tilapia against S. agalactiae infection has been
reported in Thailand (Kitancharoen et al., 2006; Boonya-
wiwat et al., 2007). This article aims to study the protective
effect  of  vaccine  against  S.  iniae  infection  in  tilapia  by
different routes of administration. In addition, the effect of
-(1,3/1,6)–glucan on the effectiveness of S. iniae vaccine
in red tilapia is reported in this study.
2. Materials and Methods
2. 1Bacterium
S. iniae isolated from previous reports (Suanyuk et
al., 2010) was used in this study. The bacterium was cultured
in tryptic soy broth (TSB: Merck) and maintained on tryptic
soy agar (TSA: Merck) and incubated at 35°C for 24-48 hrs.
2.2 Experimental animals
Healthy  and  Streptococcus  spp.  free  red  tilapia  O.
niloticus x O. mossambicus with an average weight of 7.74
1.59 g were used as experimental animals. Fish were main-
tained in 100 L fiberglass tank containing 20 fish per tank.
Water exchange was carried out daily at 20% level and indi-
vidual tank was provided proper aeration. The temperature
was maintained at 26.321.14, pH at 7.110.22 and alkalinity
at 28.677.65 for the entire experimental duration.
2.3 Vaccine
2.3.1  Injection and immersion vaccine
S. iniae was grown aerobically in 4 L of TSB at 35°C
for 24 hrs. Cells in the late stationary phase were examined
for purity by spreading onto TSA and incubated at 35°C for
24 hrs. A total plate count was performed for cell enumera-
tion and formalin was added at 1% (v/v final concentration).
After 24 hrs, cells were checked for sterilization by spreading
onto TSA and harvested by centrifugation at 10,000 rpm at
4°C for 10 min. The cells were then washed three times with
0.85% NaCl and diluted to 1x10
10 CFU/ml using 0.1% formalin
in 0.85% NaCl as a preservative and stored at 4°C until use.
To produce a vaccine with adjuvant, the vaccine was emulsi-
fied  in  an  equal  volume  of  2% -(1,3/1,6)–glucan  from
Saccharomyces cerevisiae (MacroGard
® AquaSol, Biorigin
Scandinavia AS, Norway) to achieve final vaccine concen-
tration of 1x10
10 CFU/ml and stored at 4°C until used.
2.3.2  Oral vaccine
S. iniae was cultured as described for injection and
immersion administration. After 24 hrs, cells were checked for
sterilization, harvested and washed three times with 0.85%
NaCl. The harvested cells were dehydrated using FreeZone
®
6 liter console freeze-dry system with shell freezer (Labconco
corporation, Missouri). The dehydrated cells were incorpo-
rated in feed for oral administration. Two isonitrogenous test
diets were formulated to contained 30% protein, 7% fat, and
5%  fiber.  All  diets  have  the  same  composition  except  the
level of vaccine added to achieve 0 and 1% for control and
experimental diet, respectively. The composition of the test
diets is shown in Table 1.
2.4 Vaccination procedure
Red tilapia was used for comparing the degree of pro-
tection attained by fish vaccinated with different methods
as follows: T1 (control) fish were hand-fed twice daily with
Table 1. Composition of experimental diets.
g/kg
             Ingredients
Control Treatment
Fish meal 120 120
Soybean meal 400 400
Broken rice 100 100
Palm kernel cake 140 140
Rice flour 100 90
Fish oil 20 20
Vitamin & Mineral mixed
a 10 10
Choline chloride 6 6
Rice bran 104 104
Vaccine (Freeze dried cell) - 10
Total 1000 1000
a Vitamin and mineral mixture supplemented per kilogram feed:
Thiamine (B1) 10 mg; Riboflavin (B2) 20 mg; Pyridoxine (B6)
10 mg; Cyanocobalamine (B12) 2 mg; Retinal (A) 4,000 IU;
Cholecalciferol  (D3)  2,000  IU;  Menadione  sodium bisulfite
(K3) 80 mg; Folic acid 5 mg; Calcium pantothenate 40 mg;
Inositol 400 mg; Niacin 150 mg; DL-alpha-tocopherol (E) 50
IU;  Choline  chloride  6,000  mg;  Ascorbic  acid  (C)  500  mg;
Biotin  1  mg;  NaCl  0.25  g;  MgCO3  3.75  g;  FeSO4  0.72  g;
(CH3COO)2Ca·5H2O 0.88 g; ZnSO4·7H2O 0.088 g; MnSO4·
4H2O 0.040 g; CuSO4·5H2O 0.008 g; CoCl2·6H2O 0.00025 g;
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control  diet  to  apparent  satiation,  T2  injected  with  pure
vaccine by intraperitoneal injection (0.1 ml/fish) and hand-
fed  twice  daily  with  control  diet  to  apparent  satiation,  T3
injected with vaccine plus glucan by intraperitoneal injection
(0.1 ml/fish) and hand-fed twice daily with control diet to
apparent satiation, T4 immersed in water containing 10%
pure  vaccine  for  30  sec  prior  to  release  to  aquarium  and
hand-fed twice daily with control diet to apparent satiation,
T5 hand-fed twice daily with basal diet supplemented with
1%  freeze-dried  vaccine  to  apparent  satiation  for  1  week
followed by hand-fed twice daily with control diet to apparent
satiation.
2.5 The efficacy test of vaccine
2.5.1  Effect of vaccine on antibody production
At one and four weeks post vaccination, six fish from
each treatment were assayed for the presence of S. iniae-
specific agglutinating antibody in the plasma. Experimental
fish were anaesthetized with quinaldine (Coyle et al., 2004).
Blood was then withdrawn from the caudal vein using a 1-ml
syringe coated with a dry film of 1% ethylene diaminetetra-
acetic acid (EDTA) and the plasma was collected by centrifu-
gation at 3,000 rpm and 4°C for 10 min.
A two-fold dilution of plasma collected from immun-
ized fish was made in 0.1% formalin in 0.85% NaCl. The
antigen was mixed (1:1) into each dilution, left the samples
at room temperature for 2 h then stored in refrigerator at 4°C.
The results were read visually after 22 hrs of incubation at
4°C.  The  end-point  titer  was  taken  as  the  last  well  where
agglutination was seen.
2.5.2  Blood parameters
Effect of vaccine on blood parameters was studied
at one and four weeks post vaccination. Six fish from each
treatment were used and fish blood collection was performed
as  described  in  Section  2.5.1.  Haematocrit,  was  measured
using a method of Larsen and Snieszko (1961), blood cell
count was measured using a method of Supamattaya (1995),
haemoglobin was measured by the method of Blaxhall and
Daisley (1973), and plasma protein level was determined by
the modification method of Lowry et al. (1951), see Supa-
mattaya et al. (2000).
2.5.3  Disease resistance
At one and four weeks post vaccination, a challenge
procedure was performed by intraperitoneal injection of 0.1
ml of S. iniae at cell concentration of approximately 5x10
7
CFU/fish. Each experiment was conducted using triplicate
tanks  with  20  fish  per  replication.  The  mortalities  were
recorded daily for 21 days and tissue samples of fish were
collected and bacterial cells isolated to confirm S. iniae as
the cause of death. The RPS was calculated for each vaccine
according to the method described below (Ellis, 1998).
Percent vaccinate mortality
RPS 1 100
Percent control mortality
  
2.6 Statistical analysis
Data from the present study was expressed as a mean
with standard deviation. Significant differences were analyzed
using one way ANOVA (CRD) and the differences among
means using Duncan’s multiple range test (Steel and Torrie,
1980). A P value of <0.05 was considered statistically signifi-
cant.
3. Results
3.1 Efficacy test of vaccine at one week post vaccination
At one week post vaccination, antibody productions
of fish vaccinated with S. iniae vaccine in every treatment
were higher than those of the control (Table 2). The highest
antibody production was observed in fish intraperitoneally
injected with S. iniae vaccine (Table 2). The plasma protein
and red blood cell of fish vaccinated with vaccine plus glucan
Table 2. Humoral antibody titers of red tilapia vaccinated with formalin-killed S. iniae
vaccine. Titers were determined 1 and 4 week after vaccination.
     Antibody titer
1
                                     Treatment
1 week 4 weeks
T1 : Control 0.000.00
a 0.000.00
a
T2 : Injection (pure vaccine) 1.400.46
c 1.100.35
b
T3 : Injection (vaccine plus glucan) 1.400.17
c 1.200.00
b
T4 : Immeresion (10% vaccine, 30 sec) 0.900.30
bc 0.400.35
a
T5 : Oral (basal diet plus 1% freeze dried vaccine) 0.700.17
b 0.400.46
a
1Log reciprocal of the greatest plasma dilution in which agglutination of S. iniae occurred;
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were significantly higher than those of the control. No signi-
ficant difference in the haematocrit, haemoglobin, and white
blood cell was observed between vaccinated and non-vacci-
nated fish (Table 3).
Vaccination  of  red  tilapia  with  S.  iniae  vaccine
provided  significant  levels  of  protection  in  all  treatments
challenged  with  S.  iniae  after  1  week  of  vaccination.  The
survival rate, mean percent mortality and RPS of S. iniae
vaccinated  and  non-vaccinated  tilapia  following  S. iniae
challenge are shown in Figure 1 and 2. Fish given vaccine
plus glucan by injection had RPS of 95.12% followed by pure
vaccine injection with RPS of 80.49%. Immersion and oral
vaccination provided RPS of 41.46 and 9.75%, respectively
(Figure 2).
3.2 Efficacy test of vaccine at four weeks post vaccination
At four weeks post vaccination, antibody production
of fish vaccinated by injection with S. iniae pure vaccine and
vaccine plus glucan were significantly higher (p<0.05) than
those  of  the  fish  vaccinated  by  immersion,  oral  and  non
vaccinated control fish (Table 2). Similar levels of the heama-
tocrit, haemoglobin, plasma protein and red and white blood
cell of fish immunized via different routes (p<0.05) after 4
weeks with S. iniae vaccine was observed (Table 4).
Vaccination  of  red  tilapia  with  S.  iniae  vaccine
provided significant levels of protection in every treatment
challenged  after  4  weeks  with  S.  iniae.  The  survival  rate,
mean percent mortality and RPS of S. iniae vaccinated and
non-vaccinated  tilapia  following  S.  iniae  challenge  are
shown in Figure 3 and 4. Fish given vaccine plus glucan by
injection had a RPS of 76.00% which is higher than those
vaccinated with pure vaccine with RPS of 54.00%. Immersion
and oral vaccination provided less protection with RPS of
-4.00 and -8.00%, respectively (Figure 4).
Table 3. Mean blood parameters values and, in parenthesis, ranges for red tilapia immunized with S. iniae vaccine.
Blood parameters were determined 1 week after vaccination.
                                Treatment Haematocrit Haemoglobin Plasma protein RBC
1 WBC
2
(%) (g/dl) (mg/ml) (x10
6 cell/mm
3) (x10
4 cell/mm
3)
T1 : Control 26.443.55
ns 6.511.15
ns 43.799.47
a 1.670.43
a 4.101.13
ns
(23.08-32.39) (5.22-8.18) (31.07-53.23) (0.99-2.16) (2.13-5.03)
T2 : Injection (pure vaccine) 26.253.06
ns 6.781.32
ns 45.573.31
ab 2.120.54
ab 4.691.08
ns
(21.69-29.27) (4.83-8.02) (41.90-49.90) (1.41-3.07) (3.18-6.08)
T3 : Injection (vaccine plus glucan) 24.885.93
ns 6.881.20
ns 52.153.09
b 2.730.69
b 4.722.03
ns
(19.18-31.75) (5.22-8.72) (48.90-57.73) (1.96-3.76) (2.65-8.23)
T4 : Immeresion (10% vaccine, 30 second) 25.031.64
ns 7.501.36
ns 46.263.90
ab 1.850.38
a 4.551.29
ns
(22.22-26.25) (5.53-9.46) (40.90-50.57) (1.40-2.46) (3.05-6.68)
T5 : Oral (basal diet plus 1% freeze dried vaccine) 26.533.61
ns 7.270.65
ns 45.186.76
ab 1.690.48
a 4.171.02
ns
(20.83-30.26) (6.58-8.25) (37.07-57.07) (1.22-2.40) (2.30-5.28)
1 RBC; Red blood cell, 
2 WBC; White blood cell, Means within columns not sharing the same superscript are significantly different
(p<0.05).
Figure 1. Survival  rate  of  red  tilapia  challenged  with  S.  iniae  (1
week post vaccination). Value with different letters are
significantly different (p<0.05).
Figure 2. Mortality rate and relative percent survival of red tilapia
immunized  with  formalin - killed  S.  iniae  vaccine  and
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4. Discussions
S. iniae has great impact on the Asian sea bass and
tilapia  cultivation  in  Thailand.  Presently,  streptococcosis
occurs in various aquaculture areas throughout the country.
Studies on the application of streptococcosis vaccines are
necessary to assess preventive measures against the damage
caused  by  this  disease.  In  this  study,  potency  testing
revealed that the vaccine is safe with no mortality or disease
signs were observed in fish vaccinated with S. iniae vaccine
within 10 days post vaccination (data not shown). In general,
a vaccine must simulate that natural defense in producing
immunity, but it must not produce clinical illness. Killed or
inactivated vaccines are usually safer than live vaccines, but
even these can produce unwanted side effect (Ellis, 1998).
Effective vaccines have been developed against S.
iniae for delivery by injection (Eldar et al., 1997; Klesius et
al., 1999; 2000). Findings of the present study indicate that
injection of formalin-killed S.iniae vaccine provides higher
level of protection than those of immersion and oral vaccina-
tion. Eldar et al. (1997) reported that vaccination of rainbow
trout by intraperitoneal injection of a formalin killed bacterin
of S. iniae resulted in antibody production in vaccinated
fish. After challenging with a virulent strain of S. iniae, un-
vaccinated  fish  had  a  mortality  rate  greater  than  50%
compared to vaccinated fish with a mortality rate less than
5%.
-glucan are structural polysaccharides in the cell
walls of most yeasts (Manner et al. 1973; Robertsen et al.,
1990; Chen and Ainsworth 1992), brown algae (Dalmo and
Seljelid,  1995;  Dalmo  et  al.,  1995)  and  fungi  (Brown  and
Gordon, 2003). The present study showed that intraperito-
neal injection of vaccine plus glucan enhanced better pro-
tection than those of pure vaccine. This may be explained by
the  fact  that  -glucan  activated  both  specific  and  non-
specific immunity such as increasing the specific antibody
Table 4. Me an blood parameters values and, in parenthesis, ranges for red tilapia immunized with S. iniae vaccine.
Blood parameters were determined week 4 after vaccination.
                                Treatment Haematocrit Haemoglobin Plasma protein RBC
1 WBC
2
(%) (g/dl) (mg/ml) (x10
6 cell/mm
3) (x10
4 cell/mm
3)
T1 : Control 26.639.27
ns 7.402.16
ns 65.896.43
ns 1.990.54
ns 5.261.91
ns
(12.09-35.29) (3.47-9.42) (56.22-74.04) (1.14-2.78) (2.65-7.40)
T2 : Injection (pure vaccine) 27.695.46
ns 7.921.14
ns 63.6414.25
 ns 2.390.33
ns 4.650.71
ns
(19.57-36.00) (6.39-9.54) (52.04-89.67) (1.92-2.94) (3.48-5.45)
T3 : Injection (vaccine plus glucan) 27.006.54
ns 7.081.43
ns 69.6411.31
 ns 2.360.41
ns 5.761.14
ns
(17.14-35.87) (4.52-8.53) (57.67-80.95) (1.72-2.90) (3.90-7.18)
T4 : Immeresion (10% vaccine, 30 second) 33.847.07
ns 8.391.35
ns 57.557.43
 ns 2.410.39
ns 4.021.39
ns
(28.41-47.62) (6.39-10.04) (49.49-68.95) (2.00-2.90) (2.20-5.68)
T5 : Oral (basal diet plus 1% freeze dried vaccine) 26.965.50
ns 7.780.88
ns 56.584.58
 ns 2.260.34
ns 4.411.35
ns
(22.22-34.02) (6.46-8.80) (49.49-61.85) (1.90-2.87) (2.90-6.38)
1 RBC; Red blood cell, 
2 WBC; White blood cell, Means within columns not sharing the same superscript are significantly different
(p<0.05).
Figure 3. Survival  rate  of  red  tilapia  challenged  with  S.  iniae (4
weeks post vaccination). Value with different letters are
significantly different (p<0.05).
Figure 4. Mortality rate and relative percent survival of red tilapia
immunized  with  formalin - killed  S.  iniae  vaccine  and
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secreting cells and specific humoral immune response (anti-
body production) (Siwicki et al., 2004), activating the element
of the non-specific defense mechanisms, including macro-
phages, neutrophils, thrombocytes, complement and lyso-
zyme (Matsuyama et al., 1992; JØrgensen et al., 1993) and
enhancement  of  fish  resistance  to  bacterial  infections
(Robertsen et al., 1990; Matsuyama et al., 1992).
In this study, immersion vaccination provided lower
protection than those given by injection. Killed vaccines are
generally administered by injection in order to achieve good
efficacy. Evans et al. (2004) demonstrated that bath immuni-
zation of tilapia resulted in RPS values that were two times
lower than those achieved with intraperitoneal vaccination.
Although the injected vaccination provides excellent
protection, they are labor-intensive and usually induce stress.
A potential mass delivery strategy is oral administration via
feed (Vandenberg, 2004) which has been used successfully
against  a  variety  of  bacterial  diseases  (Lillehaug,  1989;
Plumb and Vinitnantharat, 1994; Kawai and Hatamoto, 1999;
Park et al., 2001). In this study, attempt with oral vaccination
using  killed  S. iniae  vaccine  has  been  unsuccessful.  Oral
vaccine in the present study was prepared by the addition of
bacterial cells to feed without a carrier or protective coating.
This might lead to the damage of antigen during digestive
process. Improvement or modification of bacterin incorpor-
ated in fish feed such as the use of alginate microparticles
containing formalin-killed bacterin (Romalde et al., 2004)
or Oralject™ technology which relies on the temporary re-
duction of the digestive processes by administration of anti-
proteases and membrane permeability enhancers in combina-
tion with the vaccine (Vandenberg, 2004; Shoemaker et al.,
2006) may permit the antigen to escape digestive hydrolysis
and have enhanced vaccine component uptake.
In summary, formalin-killed S. iniae vaccine provided
excellent  efficacy  against  S.  iniae  infection  in  tilapia  by
intraperitoneally injection method and -(1,3/1,6)–glucan
increased  the  effectiveness  of  vaccine  produced  from  S.
iniae  in  fish.  Immersion  and  oral  vaccination  showed  less
effect  on  disease  protection  at  week  4  post  vaccination
suggesting that increasing immersion time, vaccine concen-
tration or booster vaccination may be needed to increase
protection. Further studies on vaccination of S. iniae vaccine
in tilapia under field condition need to be investigated.
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